Place of phosphatidylcholine in the treatment of inflammatory bowel disease
Journal Title: Гастроентерологія - Year 2017, Vol 51, Issue 3
Abstract
In the pathogenesis of most diseases of the intestine, inflammation is important, and, often, critical. Its pathogenetic role in the inflammatory bowel disease was studied broadly and comprehensively. In recent years, research has begun on its contribution to intestinal damage in functional pathology — irritable bowel syndrome. The participation of inflammation in the development of erosive and ulcerative lesions of the lower gastrointestinal tract on the background of non-steroidal anti-inflammatory drugs (NSAID-enterocolopathy) seems paradoxical. The role of phospholipids in the construction of cell membranes is well known. One of the main membrane phospholipids of most living organisms (with the exception of microbes) is phosphatidylcholine (PC). In membranes of the intestinal epithelium, the content of PC increases from 10 to 50 % in the direction from the apical surface to the basal one, and the maximum amount of PC is located on the outside of the cell membranes. Phosphatidylcholine showed its high efficacy and safety in the treatment of inflammatory bowel diseases, such as non-specific ulcerative colitis. People taking NSAIDs have demonstrated the protective role of PC in preventing damage to the upper and lower gastrointestinal tract. Given the common pathogenetic mechanisms between these diseases and irritable bowel syndrome, the use of PC in patients with irritable bowel syndrome seems promising, especially in its post-infection variant.
Authors and Affiliations
A. E. Dorofeev, N. N. Rudenko, N. I. Shvets, A. A. Dorofeeva
Keywords
Related Articles
- EP ID EP231303
- DOI 10.22141/2308-2097.51.3.2017.112637
- Views 66
- Downloads 0
Clinical and Epidemiological Features of Hepatitis among the Residents of the Transcarpathian Region
The clinical and epidemiological features of hepatitis A in the Transcarpathian region for years 2004–2014 were indicated. A specific cyclicism and seasonality of hepatitis A in this region of Ukraine was established. Ba...
Features of Pancreatic Pathology in Children
Background. The prevalence of pancreatitis in children with digestive disorders is 5–25 %. Aim of research: to determine the prevalence of pancreatic pathology in children. Material and methods. The research was conducte...
Proton Pump Inhibitors: How Safe is Long Usage of Pantoprazole?
The article deals with the approaches to treatment of acid-related diseases, there was determined key role of proton pump inhibitors. The special attention was given to safety of long usage of proton pump inhibitors, the...
Imbalance of kallikrein-kinin system in chronic pancreatitis combined with obesity and results of its comprehensive correction
Background. Chronic pancreatitis is one of the most common diseases in general therapeutic practice. Significant role in the onset and progression of chronic pancreatitis is played by the activation of the kallikrein-kin...
Functional constipation at a young age. Place of macrogol 4000 (Forlax) in the treatment
Background. Considering the wide prevalence of functional constipation (FC) at a young age, we set ourselves the task of comparing the effectiveness of osmotic laxative macrogol 4000 (Forlax) in the treatment of FC in ad...